Hot Pursuit     30-Jun-23
Zydus Lifesciences Ltd soars 0.09%, rises for fifth straight session
Zydus Lifesciences Ltd is quoting at Rs 583, up 0.09% on the day as on 12:44 IST on the NSE. The stock is up 61.36% in last one year as compared to a 21.45% gain in NIFTY and a 12.38% gain in the Nifty Metal.

Zydus Lifesciences Ltd gained for a fifth straight session today. The stock is quoting at Rs 583, up 0.09% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.84% on the day, quoting at 19130.9. The Sensex is at 64495.2, up 0.91%. Zydus Lifesciences Ltd has added around 16.07% in last one month.

Meanwhile, Nifty Metal index of which Zydus Lifesciences Ltd is a constituent, has added around 8.68% in last one month and is currently quoting at 13622.75, up 1.15% on the day. The volume in the stock stood at 8.61 lakh shares today, compared to the daily average of 12.37 lakh shares in last one month.

The benchmark July futures contract for the stock is quoting at Rs 587.05, up 0.7% on the day. Zydus Lifesciences Ltd is up 61.36% in last one year as compared to a 21.45% gain in NIFTY and a 12.38% gain in the Nifty Metal index.

The PE of the stock is 35.02 based on TTM earnings ending March 23.

Previous News
  Sensex up 203 pts, oil & gas shares advance
 ( Market Commentary - Mid-Session 24-Apr-24   14:36 )
  Indices trade with moderate losses; PSU bank shares decline
 ( Market Commentary - Mid-Session 23-Jul-24   14:31 )
  Zydus receives USFDA approval for Valsartan Tablets
 ( Corporate News - 23-Jul-24   15:20 )
  Zydus Life rises on USFDA nod for heart failure drug
 ( Hot Pursuit - 10-Jul-24   15:36 )
  Zydus Life declines after US FDA concludes manufacturing facility inspection with 10 observations
 ( Hot Pursuit - 24-Apr-24   13:24 )
  Zydus Lifesciences receives USFDA tentative approval for Diroximel Fumarate Delayed-Release Capsules
 ( Corporate News - 10-Jul-24   16:03 )
  Zydus receives USFDA approval for Sacubitril and Valsartan Tablets
 ( Corporate News - 10-Jul-24   16:12 )
  Zydus Life gets final approval from USFDA for hypertension drug
 ( Hot Pursuit - 23-Jul-24   12:10 )
  Zydus Lifesciences consolidated net profit rises 26.76% in the December 2023 quarter
 ( Results - Announcements 09-Feb-24   14:29 )
  Zydus Life gets US FDA nod for anti-cancer medication Cyclophosphamide
 ( Hot Pursuit - 14-Dec-23   14:31 )
  Zydus Life Ahmedabad unit gets 6 observations
 ( Hot Pursuit - 23-Dec-23   15:08 )
Other Stories
  Tata Motors total sales drop 11% YoY in Sept’24
  01-Oct-24   15:33
  Vipul Organics hits all-time high after board OKs Rs 25 cr right issue
  01-Oct-24   15:06
  Magellanic Cloud Ltd leads losers in 'A' group
  01-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  01-Oct-24   14:45
  GE Power India rises on bagging order worth Rs 240-cr
  01-Oct-24   14:41
  Volumes jump at Caplin Point Laboratories Ltd counter
  01-Oct-24   14:30
  TVS Motor registers 20% growth in September 2024 sales; Q2 total sales at 12.28 lakh units
  01-Oct-24   14:07
  Oil and Gas shares slide
  01-Oct-24   14:00
  Telecom shares fall
  01-Oct-24   14:00
  Real Estate stocks slide
  01-Oct-24   14:00
Back Top